T1	Age 2 13	64 year old
T2	Sex 14 20	female
T3	Disease_disorder 31 34	HHT
E1	Disease_disorder:T3 
#1	AnnotatorNotes E1	Hereditary hemorrhagic telangiectasia
T4	Clinical_event 38 46	referred
E2	Clinical_event:T4 
T5	Sign_symptom 75 84	epistaxis
E3	Sign_symptom:T5 
T6	Duration 89 104	nearly 50 years
E4	Duration:T6 
R1	MODIFY Arg1:E4 Arg2:E3	
T7	Detailed_description 65 74	recurrent
R2	MODIFY Arg1:T7 Arg2:E3	
T8	Coreference 128 136	symptoms
E5	Coreference:T8 
R3	IDENTICAL Arg1:E5 Arg2:E3	
T9	Coreference 166 175	condition
E6	Coreference:T9 
R4	IDENTICAL Arg1:E6 Arg2:E1	
T10	Date 137 156	since the age of 16
E7	Date:T10 
T12	Family_history 191 245	All three of her siblings also were diagnosed with HHT
T18	Date 306 323	Eight years prior
E11	Date:T18 
T20	Therapeutic_procedure 371 387	septodermoplasty
E13	Therapeutic_procedure:T20 
T21	Detailed_description 360 370	left-sided
R9	MODIFY Arg1:T21 Arg2:E13	
T22	Therapeutic_procedure 402 411	rhinotomy
E14	Therapeutic_procedure:T22 
T23	Detailed_description 394 401	lateral
R10	MODIFY Arg1:T23 Arg2:E14	
R11	SUB_PROCEDURE Arg1:E14 Arg2:E13	
T24	Coreference 427 436	operation
E15	Coreference:T24 
R12	IDENTICAL Arg1:E15 Arg2:E13	
T25	Sign_symptom 484 492	symptoms
E16	Sign_symptom:T25 
A1	TREND E16 DEC
T26	Sign_symptom 519 528	epistaxis
E17	Sign_symptom:T26 
T27	Lab_value 533 546	under control
R13	MODIFY Arg1:T27 Arg2:E17	
T28	Medication 572 583	thalidomide
E18	Medication:T28 
T29	Dosage 563 571	low dose
R14	MODIFY Arg1:T29 Arg2:E18	
T30	Clinical_event 602 610	referred
E19	Clinical_event:T30 
T31	Nonbiological_location 618 624	clinic
R15	MODIFY Arg1:T31 Arg2:E19	
T32	Sign_symptom 642 651	epistaxis
E20	Sign_symptom:T32 
A2	TREND E20 INC
T35	Duration 675 699	over the prior 12 months
E21	Duration:T35 
T36	Therapeutic_procedure 728 740	transfusions
E22	Therapeutic_procedure:T36 
A3	TREND E22 INC
T37	Clinical_event 757 769	consultation
E23	Clinical_event:T37 
T38	Sign_symptom 826 835	epistaxis
E24	Sign_symptom:T38 
T39	Biological_structure 815 825	left sided
T40	Frequency 802 807	daily
R18	MODIFY Arg1:T40 Arg2:E24	
R19	MODIFY Arg1:T39 Arg2:E24	
T41	Severity 808 814	severe
R20	MODIFY Arg1:T41 Arg2:E24	
T42	Medication 874 885	bevacizumab
E25	Medication:T42 
T43	Administration 866 873	topical
R21	MODIFY Arg1:T43 Arg2:E25	
T44	Medication 895 910	tranexamic acid
E26	Medication:T44 
T45	Administration 890 894	oral
R22	MODIFY Arg1:T45 Arg2:E26	
T46	Duration 844 858	several months
E27	Duration:T46 
T47	Medication 937 941	iron
E28	Medication:T47 
T48	Therapeutic_procedure 946 964	blood transfusions
E29	Therapeutic_procedure:T48 
T49	Administration 925 936	intravenous
R23	MODIFY Arg1:T49 Arg2:E28	
T50	Frequency 965 981	every two months
R24	MODIFY Arg1:T50 Arg2:E29	
R25	MODIFY Arg1:T50 Arg2:E28	
T51	Diagnostic_procedure 996 1006	hemoglobin
E30	Diagnostic_procedure:T51 
T52	Clinical_event 1026 1038	consultation
E31	Clinical_event:T52 
T53	Lab_value 1043 1049	75 g/L
R26	MODIFY Arg1:T53 Arg2:E30	
T54	Diagnostic_procedure 1080 1108	HHT epistaxis severity score
E32	Diagnostic_procedure:T54 
T55	Lab_value 1118 1124	severe
R27	MODIFY Arg1:T55 Arg2:E32	
T56	Lab_value 1126 1147	normalized score 9.49
R28	MODIFY Arg1:T56 Arg2:E32	
T57	Diagnostic_procedure 1153 1164	examination
E33	Diagnostic_procedure:T57 
T58	Sign_symptom 1183 1197	telangiectasia
E34	Sign_symptom:T58 
T59	Detailed_description 1174 1182	multiple
R29	MODIFY Arg1:T59 Arg2:E34	
T60	Biological_structure 1205 1212	fingers
T61	Biological_structure 1214 1218	face
T62	Biological_structure 1220 1224	lips
T63	Biological_structure 1229 1235	palate
R30	MODIFY Arg1:T60 Arg2:E34	
R31	MODIFY Arg1:T61 Arg2:E34	
R32	MODIFY Arg1:T62 Arg2:E34	
R33	MODIFY Arg1:T63 Arg2:E34	
T64	Diagnostic_procedure 1241 1263	endoscopic examination
E35	Diagnostic_procedure:T64 
T65	Sign_symptom 1283 1297	telangiectasia
E36	Sign_symptom:T65 
T66	Detailed_description 1273 1282	bilateral
R34	MODIFY Arg1:T66 Arg2:E36	
T67	Biological_structure 1308 1320	nasal septum
R35	MODIFY Arg1:T67 Arg2:E36	
T68	Sign_symptom 1342 1350	crusting
E37	Sign_symptom:T68 
T69	Severity 1332 1341	extensive
R36	MODIFY Arg1:T69 Arg2:E37	
T70	Biological_structure 1368 1385	left nasal cavity
R37	MODIFY Arg1:T70 Arg2:E37	
T71	Diagnostic_procedure 1401 1413	manipulation
E38	Diagnostic_procedure:T71 
T72	Sign_symptom 1444 1453	epistaxis
E39	Sign_symptom:T72 
R38	CAUSE Arg1:E38 Arg2:E39	
T73	Severity 1436 1443	profuse
T74	Detailed_description 1426 1435	immediate
R39	MODIFY Arg1:T73 Arg2:E39	
R40	MODIFY Arg1:T74 Arg2:E39	
T75	Therapeutic_procedure 1564 1580	septodermoplasty
E40	Therapeutic_procedure:T75 
T76	Detailed_description 1553 1563	left-sided
T77	Detailed_description 1542 1552	endoscopic
R41	MODIFY Arg1:T77 Arg2:E40	
R42	MODIFY Arg1:T76 Arg2:E40	
T78	Therapeutic_procedure 1843 1863	endoscopic procedure
E41	Therapeutic_procedure:T78 
T79	Therapeutic_procedure 1921 1931	intubation
E42	Therapeutic_procedure:T79 
T80	Detailed_description 1908 1920	endotracheal
R43	MODIFY Arg1:T80 Arg2:E42	
R44	SUB_PROCEDURE Arg1:E42 Arg2:E41	
T81	Medication 1884 1902	general anesthesia
E43	Medication:T81 
R45	SUB_PROCEDURE Arg1:E43 Arg2:E41	
T82	Therapeutic_procedure 1954 1962	prepared
E44	Therapeutic_procedure:T82 
T83	Biological_structure 1937 1949	nasal cavity
R46	MODIFY Arg1:T83 Arg2:E44	
T84	Medication 2003 2013	adrenaline
E45	Medication:T84 
T85	Dosage 2015 2021	1:1000
R47	MODIFY Arg1:T85 Arg2:E45	
T86	Administration 1995 2002	topical
R48	MODIFY Arg1:T86 Arg2:E45	
T87	Biological_structure 2033 2046	both nostrils
R49	MODIFY Arg1:T87 Arg2:E44	
T88	Detailed_description 1966 1984	inserting pledgets
R50	MODIFY Arg1:T88 Arg2:E44	
R51	MODIFY Arg1:E45 Arg2:T88	
T89	Therapeutic_procedure 2147 2156	dissected
E46	Therapeutic_procedure:T89 
T90	Detailed_description 2065 2094	Using a zero degree endoscope
T91	Biological_structure 2099 2142	residual STSG and mucosa of the left septum
R52	MODIFY Arg1:T91 Arg2:E46	
R53	MODIFY Arg1:T90 Arg2:E46	
T92	Detailed_description 2157 2186	in a supraperichondrial plane
R54	MODIFY Arg1:T92 Arg2:E46	
T93	Sign_symptom 2237 2247	hemorrhage
E47	Sign_symptom:T93 
T94	Detailed_description 2229 2236	diffuse
T95	Severity 2217 2228	significant
R55	MODIFY Arg1:T94 Arg2:E47	
R56	MODIFY Arg1:T95 Arg2:E47	
R57	CAUSE Arg1:E46 Arg2:E47	
T96	Therapeutic_procedure 2259 2269	hemostasis
E48	Therapeutic_procedure:T96 
T97	Detailed_description 2249 2258	Immediate
R58	MODIFY Arg1:T97 Arg2:E48	
T98	Detailed_description 2291 2322	topical gelatin-thrombin matrix
R59	MODIFY Arg1:T98 Arg2:E48	
T99	Detailed_description 2324 2331	Floseal
R60	MODIFY Arg1:T99 Arg2:T98	
T100	Sign_symptom 2424 2438	mucosal defect
E49	Sign_symptom:T100 
T101	Distance 2470 2474	3 cm
R61	MODIFY Arg1:T101 Arg2:E49	
T102	Detailed_description 2478 2506	anterior-posterior dimension
R62	MODIFY Arg1:T102 Arg2:T101	
T103	Therapeutic_procedure 2535 2559	skin graft was harvested
E50	Therapeutic_procedure:T103 
T104	Area 2510 2534	4 x 2 cm split thickness
R63	MODIFY Arg1:T104 Arg2:E50	
T105	Biological_structure 2569 2580	right thigh
R64	MODIFY Arg1:T105 Arg2:E50	
T106	Detailed_description 2582 2609	pie-crusted with a 15 blade
T107	Biological_structure 2641 2678	along the length of the septal defect
T108	Detailed_description 2619 2640	placed endoscopically
R65	MODIFY Arg1:T106 Arg2:E50	
R66	MODIFY Arg1:T108 Arg2:E50	
R67	MODIFY Arg1:T107 Arg2:E50	
T109	Coreference 2702 2707	graft
E51	Coreference:T109 
R68	BEFORE Arg1:E51 Arg2:E50	
T110	Biological_structure 2727 2807	overlap of the mucosa of the nasal floor and the residual superior septal mucosa
R69	MODIFY Arg1:T110 Arg2:E51	
T111	Detailed_description 2826 2840	fibrin sealant
R70	MODIFY Arg1:T111 Arg2:E50	
T112	Volume 2818 2822	2 mL
R71	MODIFY Arg1:T112 Arg2:T111	
T113	Detailed_description 2926 2985	applied first to the edges then central portion of the STSG
R72	MODIFY Arg1:T113 Arg2:T111	
T114	Therapeutic_procedure 2995 3002	Packing
E52	Therapeutic_procedure:T114 
A4	POLARITY E52 NEG
T115	Clinical_event 3053 3063	discharged
E53	Clinical_event:T115 
T116	Nonbiological_location 3064 3068	home
R73	MODIFY Arg1:T116 Arg2:E53	
T117	Date 3069 3095	on the same day of surgery
E54	Date:T117 
R74	MODIFY Arg1:E54 Arg2:E53	
T118	Clinical_event 3106 3115	follow-up
E55	Clinical_event:T118 
T119	Date 3116 3131	two weeks after
E56	Date:T119 
T120	Sign_symptom 3206 3215	epistaxis
E57	Sign_symptom:T120 
T121	Detailed_description 3195 3205	left-sided
R75	MODIFY Arg1:T121 Arg2:E57	
T122	Sign_symptom 3171 3186	graft had taken
E58	Sign_symptom:T122 
T123	Clinical_event 3321 3330	follow-up
E59	Clinical_event:T123 
T124	Date 3312 3320	6 months
E60	Date:T124 
T125	Diagnostic_procedure 3345 3355	hemoglobin
E61	Diagnostic_procedure:T125 
T126	Lab_value 3372 3379	102 g/L
R76	MODIFY Arg1:T126 Arg2:E61	
T127	Therapeutic_procedure 3402 3414	transfusions
E62	Therapeutic_procedure:T127 
T128	Frequency 3415 3429	every 4 months
R77	MODIFY Arg1:T128 Arg2:E62	
T129	Diagnostic_procedure 3539 3563	epistaxis severity score
E63	Diagnostic_procedure:T129 
T130	Lab_value 3589 3593	mild
T131	Lab_value 3595 3616	normalized score 3.05
R78	MODIFY Arg1:T130 Arg2:E63	
R79	MODIFY Arg1:T131 Arg2:E63	
T132	History 21 34	known for HHT
R80	BEFORE Arg1:E1 Arg2:E2	
T133	Nonbiological_location 54 60	clinic
R81	MODIFY Arg1:T133 Arg2:E2	
R82	AFTER Arg1:E2 Arg2:E3	
*	OVERLAP E3 E4 E5 E7 E6
T11	Family_history 250 304	her mother passed away from an intracranial hemorrhage
R5	BEFORE Arg1:E6 Arg2:E11	
*	OVERLAP E11 E13 E15 E16
T13	Duration 497 514	for several years
E8	Duration:T13 
R6	BEFORE Arg1:E16 Arg2:E8	
*	OVERLAP E8 E17 E18
R7	BEFORE Arg1:E18 Arg2:E19	
T14	Detailed_description 632 641	increased
T15	Severity 652 660	severity
T16	Frequency 665 674	frequency
R8	MODIFY Arg1:T14 Arg2:T15	
R16	MODIFY Arg1:T14 Arg2:T16	
R17	MODIFY Arg1:T15 Arg2:E20	
R83	MODIFY Arg1:T16 Arg2:E20	
R84	AFTER Arg1:E19 Arg2:E20	
*	OVERLAP E20 E21 E22
R85	BEFORE Arg1:E22 Arg2:E23	
*	OVERLAP E23 E24
R86	AFTER Arg1:E24 Arg2:E27	
*	OVERLAP E27 E25 E26 E28 E29
R87	BEFORE Arg1:E29 Arg2:E30	
*	OVERLAP E30 E31 E32 E33 E34 E35 E36 E37 E38 E39
R88	BEFORE Arg1:E39 Arg2:E40	
*	OVERLAP E40 E41 E44 E45 E46 E47 E48 E49 E50 E51
R89	BEFORE Arg1:E51 Arg2:E52	
R90	BEFORE Arg1:E52 Arg2:E53	
R91	BEFORE Arg1:E53 Arg2:E55	
*	OVERLAP E55 E56 E58 E57
A5	TREND E57 DEC
R92	BEFORE Arg1:E57 Arg2:E60	
*	OVERLAP E60 E59 E61 E62 E63
